Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors

Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aiming at enhancing antitumor immunity. Their clinical efficacy is well-documented, but the side effects associated with their use are still under investigation. These drugs cause several immune-related ad...

Full description

Bibliographic Details
Main Authors: Konstantinos Melissaropoulos, Kalliopi Klavdianou, Alexandra Filippopoulou, Fotini Kalofonou, Haralabos Kalofonos, Dimitrios Daoussis
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
immune checkpoint inhibitors
cancer immunotherapy
rheumatic
musculoskeletal
arthritis
myositis
Online Access:https://www.mdpi.com/1422-0067/21/9/3389

Internet

https://www.mdpi.com/1422-0067/21/9/3389

Similar Items